. 2017 May 12;12(5):e0177476. doi: 10.1371/journal.pone.0177476

Table 5. Rate ratio of definite or probable thrombosis.

Authors	Comparator	Thrombosis ≤ 30d	Thrombosis > 30d	Thrombosis 1 year	Long-term total thrombosis (> 1 year)
[8]	EES vs. BMS		0.43 [0.13–1.23]		0.96 [0.03–24.33]
[8]	ZES vs. BMS		4.08 [0.82–20.58]		4.09 [0.15–143.90]
[9]	EES vs. BMS			0.41 [0.22–0.72]	0.46 [0.31–0.70]
	ZES vs. BMS			1.04 [0.53–1.98]	0.69 [0.39–1.28]
	Re-ZES vs. BMS			0.61 [0.19–1.72]	0.62 [0.29–1.44]
[10]	EES vs. BMS			0.89 [0.09–8.67]	0.39 [0.18–0.82]
[10]	ZES vs. BMS			133.10 [0.56–12540]	0.69 [0.23–1.60]
[4]	EES-Pt-Cr vs. BMS	0.08 [0.00–0.96]	NA	0.34 [0.05–2.12]	NA
	EES-Co-Cr vs. BMS	0.32 [0.17–0.60]	0.42 [0.17–0.95]	0.34 [0.21–0.53]	0.92 [0.25–4.95]
	Re-ZES vs. BMS	0.32 [0.09–0.99]	1.70 [0.33–10.83]	0.53 [0.21–1.26]	0.96 [0.07–18.52]
	PC-ZES vs. BMS	1.17 [0.53–2.72]	2.10 [0.60–9.20]	1.13 [0.60–2.11]	0.91 [0.13–9.25]
[11]	EES-Co-Cr vs. BMS	0.28 [0.12–0.61]	0.73 [0.11–6.46]	0.36 [0.18–0.66]	0.41 [0.16–0.88]
[11]	PC-ZES vs. BMS	0.45 [0.15–1.12]	0.26 [0.00–4.95]	0.47 [0.19–1.04]	0.68 [0.21–1.80]
[12]	EES-Pt-Cr vs. BMS	0.16 [0.03–0.64]	3.23 [0.26->99]	0.35 [0.12–1.03]	0.43 [0.16–1.03]
	EES-Co-Cr vs. BMS	0.32 [0.18–0.57]	0.44 [0.20–0.92]	0.39 [0.27–0.57]	0.48 [0.34–0.70]
	Re-ZES vs. BMS	0.32 [0.10–0.90]	2.28 [0.47–12.88]	0.59 [0.28–1.28]	0.73 [0.35–1.55]
	PC-ZES vs. BMS	0.73 [0.38–1.43]	2.02 [0.76–5.89]	0.99 [0.62–1.55]	0.75 [0.50–1.12]
[13]	EES-Pt-Cr vs. BMS				0.58 [0.11–2.70]^*
	EES-Co-Cr vs. BMS				0.50 [0.33–0.73]^*
	Re-ZES vs. BMS				0.81 [0.34–1.70]^*
	PC-ZES vs. BMS				0.66 [0.44–1.10]^*
[14]	EES-Co-Cr vs. BMS				0.48 [0.31–0.73]
[15]	EES vs. BMS				0.37 [0.15–0.87]

Notes: BMS: Bare-metal stent, EES: Everolimus-eluting stent, ZES: Zotarolimus-eluting stent, NA: Not available

* Results at 3.8 years; significant at 5% in bold.